These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current treatment of Cutaneous T-Cell Lymphoma. Duvic M Dermatol Online J; 2001 Feb; 7(1):3. PubMed ID: 11328624 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous T cell lymphoma: update on treatment. Wollina U Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches. Querfeld C; Rosen ST; Kuzel TM; Guitart J Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of cutaneous T-cell lymphomas]. Rappersberger K; Ortel B; Forstinger C; Wolff K Wien Klin Wochenschr; 1994; 106(10):300-8. PubMed ID: 8053197 [TBL] [Abstract][Full Text] [Related]
10. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma. Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545 [TBL] [Abstract][Full Text] [Related]
11. Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL). Dummer R Semin Oncol; 2006 Feb; 33(1 Suppl 3):S33-6. PubMed ID: 16516674 [TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma. Topf S; Lüftl M; Neisius U; Brabletz T; Simon M; Schuler G; Schultz ES Eur J Dermatol; 2006; 16(1):84-6. PubMed ID: 16436350 [TBL] [Abstract][Full Text] [Related]
13. Update on treatment of cutaneous T-cell lymphoma. Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Edelson RL Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches in cutaneous lymphoma. Jörg B; Kerl H; Thiers BH; Bröcker EB; Burg G Dermatol Clin; 1994 Apr; 12(2):433-41. PubMed ID: 8045054 [TBL] [Abstract][Full Text] [Related]
16. Controversies in the management of the cutaneous T cell lymphomas. Zic JA Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms. Dummer R; Foss F; Dreno B; Bagot M Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673 [TBL] [Abstract][Full Text] [Related]
18. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II. Paulli M; Berti E Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460 [TBL] [Abstract][Full Text] [Related]